Second-Step Risk Stratification Within the FIB-4 Gray Zone in MASLD: Derivation and Temporal Validation of a Four-Variable Clinical Model
Year: 2026
Type: preprint
Abstract: Background & Aims: FIB-4 is recommended for first-line fibrosis risk assessment in MASLD, but many patients fall into the indeterminate gray zone (1.30–2.67), requiring further stratification. We tested whether a simple model using routine clinical variables improves second-step risk stratification after indeterminate FIB-4, especially when VCTE is unavailable. Methods Using NHANES data, we developed a weighted ridge logistic model in 2017–March 2020 (n = 2,709) and validated it in 2021–2023 (n = 1,543). Elevated liver stiffness was LSM ≥ 8.0 kPa. Predictors were age, BMI, ALT, and GGT. Performance was assessed by discrimination, calibration, prediction error, reclassification, decision-curve analysis, and prespecified gray-zone analyses. Results In temporal validation, the model had AUC 0.722 (95% CI 0.690–0.754) versus 0.581 (0.544–0.617) for FIB-4 (P < 0.001); survey-weighted AUCs were 0.735 and 0.562. Calibration was preserved (intercept 0.213; slope 1.014). Within the FIB-4 gray zone (n = 420; weighted LSM ≥ 8.0 kPa prevalence 23.7%), AUC was 0.697 versus 0.542 for FIB-4 (P < 0.001). Discrimination was higher than SAFE but similar to MAF-5. Thresholds 0.0923 and 0.2623 defined lower-, intermediate-, and higher-priority groups with event prevalences 8.2%, 23.8%, and 45.8%. At validation, sensitivity at the lower threshold was 90.8%; specificity at the upper threshold was 86.9%. At ~ 90% sensitivity, model-based prioritization reduced VCTE referral from 86.6% to 69.0%. Conclusion A simple four-variable model improved second-step risk stratification beyond FIB-4, particularly in the gray zone, with acceptable temporal calibration and clinically useful risk separation. It may help prioritize VCTE when access is constrained, but should complement, not replace, definitive fibrosis assessment, and requires external validation.
Source: Research Square
Authors: Zhiyi Qiu, Xinyu Zhang, Yufeng Xing
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: non-alcoholic fatty liver disease, FIB-4, clinical risk model, liver stiffness measurement, noninvasive fibrosis assessment, ALT, gamma-glutamyl transferase, body mass index, temporal validation, Scaled Agile Framework, referral prioritization, NHANES, decision curve analysis, reclassification
Open Access status: green
OpenAlex ID: W7236712902
